Autoimmune rheumatic diseases in women with coronary microvascular dysfunction: a report from the Women's Ischemia

Melanie T Chen1, Joseph Chang1, Ashley S Manchanda1

  • 1Barbra Streisand Women's Heart Center, Cedars-Sinai Smidt Heart Institute, Los Angeles, CA, United States.

Insights

Women with autoimmune rheumatic diseases (ARDs) and coronary microvascular dysfunction (CMD) experience worse functional status and myocardial perfusion. This highlights a need for further research into ARD

Area of Science:

  • Cardiology
  • Rheumatology
  • Vascular Biology

Background:

  • Autoimmune rheumatic diseases (ARDs) are linked to coronary microvascular dysfunction (CMD).
  • The impact of ARDs on CMD in women with ischemia and no obstructive arteries (INOCA) is not well understood.
  • This study investigates the relationship between ARD history and CMD outcomes in women with INOCA.

Purpose of the Study:

  • To determine if women with CMD and a history of ARD have increased angina, functional limitations, and myocardial perfusion compromise.
  • To compare outcomes in women with CMD, stratified by the presence or absence of ARD history.

Main Methods:

  • Utilized data from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) project.
  • Included women with INOCA and confirmed CMD via invasive coronary function testing.
  • Assessed Seattle Angina Questionnaire (SAQ), Duke Activity Status Index (DASI), and cardiac magnetic resonance myocardial perfusion reserve index (MPRI).

Main Results:

  • Of 207 women with CMD, 19 (9%) had a history of ARD.
  • Women with ARD were younger, had lower DASI scores (functional status), and lower MPRI (myocardial perfusion reserve).
  • A trend towards increased nocturnal and stress-induced angina was observed in women with ARD.

Conclusions:

  • Women with CMD and ARD history exhibit poorer functional status and myocardial perfusion reserve.
  • Angina symptoms and invasive coronary function did not significantly differ between groups.
  • Further research is needed to elucidate mechanisms of CMD in women with ARDs and INOCA.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
17
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
22
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
23
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
16
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
15